Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dutasteride is more effective than finasteride for hair regrowth in male and female pattern hair loss, with similar side effects.

Spironolactone does not increase the risk of breast cancer recurrence.

Women with lichen planopilaris and frontal fibrosing alopecia often have other health issues like hypothyroidism and lupus.

Lower postoperative hematocrit levels increase the risk of death within 28 days after coronary artery bypass surgery.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Excimer laser therapy may help improve scarring alopecia symptoms and hair appearance.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Hormonal intrauterine devices (IUDs) may cause or worsen skin conditions influenced by androgens.

Stressful life events may trigger alopecia areata.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

Stressful life events may trigger alopecia areata.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

FUE hair transplantation is safe and effective for improving hair loss in children.

Stabilization of fibrosing alopecia may not mean effective disease control.

Low-dose oral minoxidil for hair loss seems to have rare side effects, but more research is needed to confirm its safety.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Covid-19 vaccination during pregnancy is safe for mothers and babies.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Early-onset alopecia areata doesn't consistently predict poor long-term outcomes.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.